Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Guggenheim Downgrades AEye to Neutral

Guggenheim Downgrades AEye to Neutral

Guggenheim analyst Joseph Osha downgrades AEye (NASDAQ:LIDR) from Buy to Neutral.

byBenzinga Newsdesk

March 17, 2023

1 minute read

Guggenheim analyst Joseph Osha downgrades AEye (NASDAQ:LIDR) from Buy to Neutral.

News
Tech

Amazon Launches Affordable Virtual Care Service Amazon Clinic

By Anusuya Lahiri

November 15, 2:37 PM

Amazon.com, Inc (NASDAQ:AMZN) introduced Amazon Clinic, a message-based virtual care service that connects customers with affordable virtual care options…

AMZN

Analyst Ratings

Analyst Ratings for Rocket Companies

By Benzinga Insights

October 17, 10:11 AM

Analysts have provided the following ratings for Rocket Companies (NYSE:RKT) within the last quarter:

RKT

Silo Wellness And Marley Green Terminate Licensing Deal Over Insufficient Sales

By Lara Goldstein

October 26, 4:26 PM

A five-year license agreement signed between Silo Wellness Inc.’s (OTCQB: SILFF) wholly-owned subsidiary SW Holdings Inc.

SILFF

Nano-Cap Nexalin Technology Secures US Patent For Stimulation Device For Alzheimer’s And Dementia Treatment

By Vandana Singh

June 20, 8:40 AM

Nexalin Technology has received U.S. patent for its non-invasive Deep Intracranial Frequency Stimulation device for Alzheimer's and dementia. The device is part of a market projected to reach over $28 billion by 2030.

NXL

Guggenheim Downgrades AEye to Neutral

Related Posts

Amazon Launches Affordable Virtual Care Service Amazon Clinic

Analyst Ratings for Rocket Companies

Silo Wellness And Marley Green Terminate Licensing Deal Over Insufficient Sales

Nano-Cap Nexalin Technology Secures US Patent For Stimulation Device For Alzheimer’s And Dementia Treatment